18 October, 2019
Nablus, October 18, 2019 –Transmed Pharma concluded today participation in the First Cardiology Conference organized and hosted by An-Najah National University Hospital in Nablus. At this conference, Transmed Pharma introduced the innovative drug Vernakalant for treatment of recent-onsetof AtrialFibrillation (AF) in a presentation by Dr. Jameel Mohsen of Hillel Yaffe Medical Center in Hadera. The conference was attended by key opinion leaders and specialists in the field of cardiology from hospitals throughout Palestine.
About An-Najah Hospital The An-Najah National University Hospital was established in 2013 in cooperation with the Faculty of Medicine and Health Sciences at An-Najah National University. The Hospital is considered one of Palestine’s leading institutions in the field of health care. Since the establishment of An-Najah’s Faculty of Medicine and Health Sciences in 1999, the University has achieved numerous accomplishments in terms of medical care and health sciences, most recent of which is the establishment of the first teaching hospital in Palestine, An-Najah.
Please click here for more information.Back Next